The principal goal of the Education & Information Transfer Core (Core D) of our Alzheimer's Disease Research Center (ADRC) is to communicate information concerning issues related to aging and age-associated disorders, particularly Alzheimer's disease (AD). Using a variety of information transfer vehicles, our program is designed to reach three groups: the lay public, including members of families of affected individuals and other caregivers; medical/graduate students, clinical investigators, and basic scientists; and physicians, nurses, social workers, and other professionals working in the health care field. Outreach programs are designed to communicate with individuals, families, caregivers, lay persons, and local and regional non-academic associations of health professionals and with minority populations We have initiated a newsletter for families, caregivers, and the lay public, and are making a concerted effort to educate minorities in our region concerning AD. To train young clinicians and scientists, we have continued existing programs and have created a formal Neurobiology of Disease Training Program, which was recently funded by the NIH. This grant will provide stipends to trainees, some of whom will work on ADRC projects. The ADRC sponsors a series of lectures, seminars, opportunities for clinical/laboratory rotations and a Visiting Professor Lectureship. At the local, national, and international levels, ADRC clinicians/scientists participate in a broad range of meetings whose focus ranges from clinical issues (diagnosis, therapeutic trials, etc.), to animal models, to cellular/molecular biology. By facilitating the exchange of information, the activities of the ADRC promote public awareness, aid caregivers, health professionals, and encourage new investigators to enter the field of aging and AD. In summary, Core D helps us to realize several goals: to educate the public concerning AD and related disorders; to disseminate new findings from clinical and basic research to the lay, medial, and scientific communities for these individuals to do clinical and/or basic research.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1-PCR-3 (J5))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
United States
Zip Code
Shi, Liu; Baird, Alison L; Westwood, Sarah et al. (2018) A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication. J Alzheimers Dis 62:1181-1198
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416
Eftekharzadeh, Bahareh; Daigle, J Gavin; Kapinos, Larisa E et al. (2018) Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer's Disease. Neuron 99:925-940.e7
Kaji, Seiji; Maki, Takakuni; Kinoshita, Hisanori et al. (2018) Pathological Endogenous ?-Synuclein Accumulation in Oligodendrocyte Precursor Cells Potentially Induces Inclusions in Multiple System Atrophy. Stem Cell Reports 10:356-365
Na, Chan Hyun; Barbhuiya, Mustafa A; Kim, Min-Sik et al. (2018) Discovery of noncanonical translation initiation sites through mass spectrometric analysis of protein N termini. Genome Res 28:25-36
Johnson, Erik C B; Dammer, Eric B; Duong, Duc M et al. (2018) Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease. Mol Neurodegener 13:52
Albert, Marilyn; Zhu, Yuxin; Moghekar, Abhay et al. (2018) Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years. Brain :
Oh, Esther S; Blennow, Kaj; Bigelow, George E et al. (2018) Abnormal CSF amyloid-?42 and tau levels in hip fracture patients without dementia. PLoS One 13:e0204695

Showing the most recent 10 out of 830 publications